{"Version":{"tml_elements":["nVersionMajor","nVersionMinor"],"nVersionMinor":0,"nVersionMajor":2},"PureOrMixtureData":[{"sContributor":"TRC","PhaseID":[{"tml_elements":["ePhase"],"ePhase":"Crystal"},{"ePhase":"Liquid","tml_elements":["ePhase"]},{"tml_elements":["ePhase"],"ePhase":"Air at 1 atmosphere"}],"tml_elements":["nPureOrMixtureDataNumber","Component","eExpPurpose","sCompiler","sContributor","dateDateAdded","Property","PhaseID","NumValues"],"Component":[{"RegNum":{"tml_elements":["nOrgNum"],"nOrgNum":1},"nSampleNm":1,"tml_elements":["RegNum","nSampleNm"]}],"sCompiler":"VVD","nPureOrMixtureDataNumber":1,"dateDateAdded":"8/22/2013","NumValues":[{"tml_elements":["PropertyValue"],"PropertyValue":[{"nPropValue":443.67,"CombinedUncertainty":{"nCombExpandUncertValue":1.12,"tml_elements":["nCombUncertAssessNum","nCombExpandUncertValue"],"nCombUncertAssessNum":1},"nPropDigits":5,"nPropNumber":1,"tml_elements":["nPropNumber","nPropValue","nPropDigits","CombinedUncertainty"]}],"VariableValue":[]}],"Property":[{"nPropNumber":1,"PropPhaseID":{"ePropPhase":"Crystal","tml_elements":["ePropPhase"]},"tml_elements":["nPropNumber","Property-MethodID","PropPhaseID","ePresentation","CombinedUncertainty"],"ePresentation":"Direct value, X","CombinedUncertainty":{"nCombUncertAssessNum":1,"sCombUncertEvaluator":"Data file compiler","tml_elements":["nCombUncertAssessNum","sCombUncertEvaluator","eCombUncertEvalMethod","nCombUncertLevOfConfid"],"nCombUncertLevOfConfid":95,"eCombUncertEvalMethod":"Propagation of evaluated standard uncertainties"},"Property-MethodID":{"PropertyGroup":{"tml_elements":["PhaseTransition"],"PhaseTransition":{"tml_elements":["ePropName","sMethodName"],"sMethodName":"DTA:corrimp","ePropName":"Normal melting temperature, K"}},"tml_elements":["PropertyGroup"]}}],"eExpPurpose":"Principal objective of the work"},{"Property":[{"nPropNumber":1,"PropPhaseID":{"tml_elements":["ePropPhase"],"ePropPhase":"Crystal"},"tml_elements":["nPropNumber","Property-MethodID","PropPhaseID","ePresentation","CombinedUncertainty"],"ePresentation":"Direct value, X","Property-MethodID":{"PropertyGroup":{"PhaseTransition":{"tml_elements":["ePropName","sMethodName"],"sMethodName":"DSC","ePropName":"Molar enthalpy of transition or fusion, kJ/mol"},"tml_elements":["PhaseTransition"]},"tml_elements":["PropertyGroup"]},"CombinedUncertainty":{"nCombUncertLevOfConfid":95,"eCombUncertEvalMethod":"Propagation of evaluated standard uncertainties","tml_elements":["nCombUncertAssessNum","sCombUncertEvaluator","eCombUncertEvalMethod","nCombUncertLevOfConfid"],"sCombUncertEvaluator":"Data file compiler","nCombUncertAssessNum":1}}],"eExpPurpose":"Principal objective of the work","NumValues":[{"VariableValue":[],"PropertyValue":[{"nPropValue":41.8694336064,"CombinedUncertainty":{"nCombExpandUncertValue":1.14935700096,"tml_elements":["nCombUncertAssessNum","nCombExpandUncertValue"],"nCombUncertAssessNum":1},"nPropNumber":1,"nPropDigits":4,"tml_elements":["nPropNumber","nPropValue","nPropDigits","CombinedUncertainty"]}],"tml_elements":["PropertyValue"]}],"nPureOrMixtureDataNumber":2,"dateDateAdded":"8/22/2013","sCompiler":"VVD","Component":[{"tml_elements":["RegNum","nSampleNm"],"nSampleNm":1,"RegNum":{"nOrgNum":1,"tml_elements":["nOrgNum"]}}],"tml_elements":["nPureOrMixtureDataNumber","Component","eExpPurpose","sCompiler","sContributor","dateDateAdded","Property","PhaseID","NumValues"],"PhaseID":[{"tml_elements":["ePhase"],"ePhase":"Crystal"},{"tml_elements":["ePhase"],"ePhase":"Liquid"},{"ePhase":"Air at 1 atmosphere","tml_elements":["ePhase"]}],"sContributor":"TRC"}],"tml_elements":["Version","Citation","Compound","PureOrMixtureData"],"Citation":{"yrPubYr":"2013","sPubName":"Thermochim. Acta","dateCit":"2020-09-29","sPage":"148-55","eType":"journal","sVol":"568","eSourceType":"Original","sAbstract":"A full solid-state characterization of risperidone was conducted using differential scanning calorimetry(DSC), thermogravimetry (TG), powder X-ray diffraction (PXRD), Fourier transform infrared spectroscopy(FT-IR) and scanning electron microscopy (SEM) to examine its physicochemical properties and polymor-phism. The primary aim of this work was to study the compatibility of risperidone with pharmaceuticalexcipients using DSC to obtain and compare the curves of the active pharmaceutical ingredient (API)and the excipients with their 1:1 (w/w) binary mixtures. These same binary mixtures were turned toroom temperature and analyzed by FT-IR combined with principal component analysis (PCA) to evalu-ate solid-state incompatibilities. The chemical incompatibilities of these samples were verified using astability-indicating liquid chromatography (LC) method to assay for the API and evaluate the formationof degradation products. All of these methods showed incompatibilities between risperidone and theexcipients magnesium stearate, lactose and cellulose microcrystalline.","TRCRefID":{"yrYrPub":"2013","nAuthorn":"0","tml_elements":["yrYrPub","sAuthor1","sAuthor2","nAuthorn"],"sAuthor1":"dan","sAuthor2":"ver"},"sDOI":"10.1016/j.tca.2013.06.032","sTitle":"Risperidone   Solid-state characterization and pharmaceuticalcompatibility using thermal and non-thermal techniques","tml_elements":["TRCRefID","eType","eSourceType","sAuthor","sPubName","yrPubYr","dateCit","sTitle","sAbstract","sKeyword","sDOI","sVol","sPage"],"sAuthor":["Daniel, J. S. P.[Josiane Souza Pereira]","Veronez, I. P.[Isabela Pianna]","Rodrigues, L. L.[Larissa Lopes]","Trevisan, M. G.[Marcello G.]","Garcia, J. S.[Jerusa Simone]"],"sKeyword":["API-excipient compatibility","TG","DSC","FT-IR","Liquid chromatography"]},"Compound":[{"sStandardInChIKey":"RAPZEAPATHNIPO-UHFFFAOYSA-N","sStandardInChI":"InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3","RegNum":{"tml_elements":["nOrgNum"],"nOrgNum":1},"sFormulaMolec":"C23H27FN4O2","tml_elements":["RegNum","sStandardInChI","sStandardInChIKey","sCommonName","sFormulaMolec","Sample"],"Sample":[{"tml_elements":["nSampleNm","eSource","purity"],"purity":[{"nUnknownPerCent":99,"nUnknownPerCentDigits":2,"tml_elements":["nStep","nUnknownPerCent","nUnknownPerCentDigits","eAnalMeth"],"nStep":1,"eAnalMeth":["Stated by supplier"]}],"nSampleNm":1,"eSource":"Commercial source"}],"sCommonName":["risperidone","3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one"]}],"THERMOML_MD5_CHECKSUM":"0090ca8e3e222295a3d39877a4ef599d"}